Biogen | Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
AbbVie USD 4.55B 757M 2025-12
Acadia Pharmaceuticals USD 21.65M 913K 2025-09
ALKERMES USD 51.59M 2.13M 2025-09
Amgen USD 1.79B 128M 2025-12
Bayer EUR 4.31B 57M 2025-09
Biogen USD 810.1M 205.1M 2025-09
BioMarin Pharmaceutical USD 144.93M 10M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Gilead Sciences USD 1.62B 50M 2025-12
Incyte USD 121.18M 22.18M 2025-12
Merck USD 3.32B 531M 2025-12
Moderna USD 452M 245M 2025-12
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Novartis USD 3.54B 217M 2025-09
Pfizer USD 6.29B 2.12B 2025-12
PTC Therapeutics USD 23.32M 7.83M 2025-09
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Sangamo BioSciences 2.42M 1.11M 2024-06
Sanofi EUR 4.29B 421M 2025-12
Sanofi EUR 3.76B 344M 2025-12
Sarepta Therapeutics USD 151.45M 1.77M 2025-09
Teva Pharmaceutical Industries USD 2.06B 120M 2025-12
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
United Therapeutics USD 100.9M 74.3M 2025-09
Vertex Pharmaceuticals USD 466M 51.2M 2025-12


Biogen Biaya Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Feb 2026.